Exploring chemotherapy holiday and drugs re-challenge in advanced pancreatic cancer patients
ConclusionOur data endorse the strategy of resuming prior drugs after a chemotherapy holiday ≥ 3 months in advanced PDAC patients who achieved a durable disease control after upfront treatments.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Drugs & Pharmacology | Pancreas | Pancreatic Cancer | Taxotere | Xeloda